X-linked retinoschisis: clinical phenotype and RS1 genotype in 86 UK patients
- 1Department of Medical Genetics, University of Cambridge and Addenbrooke’s NHS Hospital Trust, Cambridge, UK
- 2Department of Ophthalmology, Addenbrooke’s NHS Hospital Trust, Cambridge, UK
- 3Department of Ophthalmology, Ninewells Hospital, Dundee, UK
- 4Biostatistics Group, Division of Epidemiology and Health Sciences, Faculty of Medical and Health Sciences, University of Manchester, UK
- 5Institute of Ophthalmology and Moorfields Eye Hospital, London, UK
- 6Academic Unit of Medical Genetics, St Mary’s Hospital and Centre for Molecular Medicine, Faculty of Medical and Health Sciences, University of Manchester, UK
- Correspondence to: Professor D Trump Academic Unit of Medical Genetics, St Mary’s Hospital, Hathersage Rd, Manchester M13 0JH, UK; dorothy.trumpman.ac.uk
- Accepted 17 January 2005
- Revised 13 January 2005
Abstract
Background: Inactivating mutations of the gene RS1 lead to X-linked retinoschisis, a progressive retinal dystrophy characterised by schisis within the inner layers of the neuroretina. The mutation spectrum is large and the phenotype variable.
Aim: To determine whether there is a correlation between mutation type and disease severity.
Methods: We identified the causative mutation in 86 affected patients and examined each of these patients in detail. Different categories of mutation were compared for each phenotypic characteristic.
Results: We found a reduction in visual acuity with increasing age and worsening macular pathology in patients over 30 years old (p≤0.001), but there was no correlation between mutation type and severity of disease. Furthermore, we found a wide variation in phenotype even within families.
Conclusions: Identifying the causative mutation in patients with X-linked retinoschisis is helpful in confirming diagnosis and in counselling of family members but cannot be used to predict prognosis for an individual patient.
- DVA, distant visual acuity
- FERG, full field electroretinogram
- NVA, near visual acuity
- XLRS, X-linked juvenile retinoschisis
Footnotes
-
We are indebted to Janice and John Pownall and Perkin-Elmer for charitable support. The study benefited from funding from the Medical Research Council, the Wellcome Trust, and the Guide Dogs for the Blind Association. DP was a Wellcome Trust Ophthalmology Training Fellow and NDLG was supported by the Guide Dogs for the Blind Association.
-
Competing interests: none declared








